Financial results - BIOREMED S.R.L.

Financial Summary - Bioremed S.r.l.
Unique identification code: 15976297
Registration number: J23/930/2010
Nace: 1089
Sales - Ron
79.159
Net Profit - Ron
19.158
Employees
1
Open Account
Company Bioremed S.r.l. with Fiscal Code 15976297 recorded a turnover of 2024 of 79.159, with a net profit of 19.158 and having an average number of employees of 1. The company operates in the field of Fabricarea altor produse alimentare n.c.a. having the NACE code 1089.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bioremed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 55.107 61.770 62.735 50.334 59.427 86.634 84.308 74.837 92.684 79.159
Total Income - EUR 56.086 62.206 68.229 47.188 57.236 100.259 91.869 97.256 94.277 87.706
Total Expenses - EUR 45.980 40.848 47.927 37.060 39.022 65.802 57.109 71.635 62.558 67.267
Gross Profit/Loss - EUR 10.107 21.358 20.302 10.128 18.214 34.457 34.760 25.621 31.719 20.439
Net Profit/Loss - EUR 8.427 20.123 19.674 9.624 17.618 33.626 33.916 24.857 30.791 19.158
Employees 1 1 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -14.1%, from 92.684 euro in the year 2023, to 79.159 euro in 2024. The Net Profit decreased by -11.461 euro, from 30.791 euro in 2023, to 19.158 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bioremed S.r.l.

Rating financiar

Financial Rating -
BIOREMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bioremed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bioremed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bioremed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bioremed S.r.l. - CUI 15976297

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 4.189 3.686 3.409 3.486 3.013 2.935 3.936 2.599 2.012 1.458
Current Assets 27.663 23.607 28.008 29.784 41.347 46.859 70.785 45.106 41.846 58.135
Inventories 7.085 11.851 15.583 15.284 9.801 26.536 27.850 23.159 18.301 21.882
Receivables 7.719 7.633 7.597 6.625 6.428 9.227 15.543 21.014 4.170 3.370
Cash 12.859 4.122 4.828 7.875 25.119 11.096 27.391 933 19.376 32.883
Shareholders Funds 28.343 21.567 21.093 30.331 42.303 34.967 63.054 26.172 41.337 56.549
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 3.509 5.726 10.323 2.939 2.057 14.826 3.296 21.534 2.521 3.043
Income in Advance 0 0 0 0 0 0 8.371 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "1089 - 1089"
CAEN Financial Year 1089
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 58.135 euro in 2024 which includes Inventories of 21.882 euro, Receivables of 3.370 euro and cash availability of 32.883 euro.
The company's Equity was valued at 56.549 euro, while total Liabilities amounted to 3.043 euro. Equity increased by 15.443 euro, from 41.337 euro in 2023, to 56.549 in 2024.

Risk Reports Prices

Reviews - Bioremed S.r.l.

Comments - Bioremed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.